Very low levels of HDL cholesterol and atherosclerosis, a variable relationship--a review of LCAT deficiency.
A number of epidemiological and clinical studies have demonstrated that plasma high-density lipoprotein (HDL) level is a strong inverse predictor of cardiovascular events. HDL is believed to retard the formation of atherosclerotic lesions by removing excess cholesterol from cells and preventing endothelial dysfunction. Lecithin cholesterol acyltransferase (LCAT) plays a central role in the formation and maturation of HDL, and in the intravascular stage of reverse cholesterol transport: a major mechanism by which HDL modulates the development and progression of atherosclerosis. A defect in LCAT function would be expected to enhance atherosclerosis, by interfering with the reverse cholesterol transport step. As such, one would expect to find more atherosclerosis and cardiovascular events in LCAT-deficient patients. But this relationship is not always evident. In this review, we describe contradictory reports in the literature about cardiovascular risks in this patient population. We discuss the paradoxical finding of severe HDL deficiency and an absence of subclinical atherosclerosis in LCAT-deficient patients, which has been used to reject the hypothesis that HDL level is important in the protection against atherosclerosis. Furthermore, to illustrate this paradoxical finding, we present a case study of one patient, referred for evaluation of global cardiovascular risk in the presence of a low HDL cholesterol level, who was diagnosed with LCAT gene mutations.
Centre d'Exploration, de Prévention et de Traitement de l'Athérosclérose, Hôpital Cardiologique, CHU Bordeaux, Université Bordeaux Segalen, Bordeaux, France.
Julia
J
Savel
Marianne
M
Lafitte
Yann
Y
Pucheu
Vincent
V
Pradeau
Antoine
A
Tabarin
Thierry
T
Couffinhal
D000818:Animals; D050197:Atherosclerosis / Q000097:blood / Q000201:enzymology / Q000209:etiology*; D015415:Biomarkers / Q000097:blood; D008076:Cholesterol, HDL / Q000097:blood*; D018450:Disease Progression; D005260:Female; D006801:Humans; D007863:Lecithin Cholesterol Acyltransferase Deficiency / Q000097:blood / Q000150:complications* / Q000201:enzymology / Q000235:genetics; D008875:Middle Aged; D009154:Mutation; D007862:Phosphatidylcholine-Sterol O-Acyltransferase / Q000235:genetics / Q000378:metabolism*; D011379:Prognosis; D018570:Risk Assessment; D012307:Risk Factors
D015415:Biomarkers; D008076:Cholesterol, HDL; D007862:Phosphatidylcholine-Sterol O-Acyltransferase